Roots Analysis
JANUARY 30, 2023
The question arises here is, does the intracellular drug delivery only applicable for cancer or any other diseases as well? It can be used to treat a variety of disorders including cardiovascular disorders, hepatic disorders, genetic disorders and many more. The answer is yes. million lives each year. But that’s not all.
Pharmaceutical Technology
SEPTEMBER 20, 2022
The production of commercial dose non-sterile products such as tablets, capsules, ointments, creams, and powders is rising due to their growing global demand, attributed to increasing demand for anti-ageing products, hereditary factors, genetic mutations, exposure to harmful radiation, and rising geriatric population.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
FEBRUARY 14, 2023
In recent years, liposomes have garnered significant interest of researchers, as well as industry players, owing to their potential in diagnosis and treatment of various diseases, with a focus on delivering drugs and genetic material.
Roots Analysis
MARCH 3, 2022
Majority of these are biologics and are being developed for the treatment of different disease conditions, including dermatological, genetic, hematological and vascular, immunological and inflammatory, infectious, neurological, ophthalmic, renal disorders. Next Generation Complement Therapeutics. Broad Clinical Trial Landscape. Web: [link].
Roots Analysis
SEPTEMBER 1, 2023
Blue Ocean Strategy Example: Foundation Medicine has developed a genomic profiling test that helps oncologists identify the best treatment options for their patients based on their genetic makeup. Furthermore, new drug delivery methods can also help reduce healthcare costs by reducing the need for frequent doctor visits and hospitalizations.
The Pharma Data
SEPTEMBER 1, 2021
Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. “These cells can sense problems and respond by producing a drug. Collins, PhD, a postdoctoral research associate in Guilak’s lab and co-first author of the study.
Roots Analysis
FEBRUARY 13, 2023
It transfers genetic information form to DNA to ribosomes, a specialized structure, or organelle, which decodes genetic information into a protein. With the help of genetic engineering, synthetic mRNAs can express proteins, as they structurally resemble a natural mRNA.
Expert insights. Personalized for you.
52 
Let's personalize your content